Prognostic value of interleukin‐6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure
- 28 October 2003
- journal article
- website
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 33 (11), 941-948
- https://doi.org/10.1046/j.1365-2362.2003.01252.x
Abstract
Background Congestive heart failure (CHF) carries a poor prognosis with a high mortality rate, frequent hospitalizations and increased risk of thrombotic complications such as stroke. Cytokines may contribute to the progression and prothrombotic state of CHF, including the pro‐inflammatory interleukin‐6 (IL‐6) and the pro‐angiogenic vascular endothelial growth factor (VEGF), both of which are raised in CHF. The procoagulant properties of both cytokines may be mediated via tissue factor (TF), a potent clotting activator. We hypothesized that plasma levels of these markers, as well as levels of plasma viscosity, fibrinogen, soluble P‐selectin and von Willebrand factor (markers of abnormal rheology, clotting, platelet activation, and endothelial damage, respectively) will be useful in predicting morbidity and mortality in chronic stable CHF. Methods and results One hundred and twenty consecutive out‐patients with chronic stable CHF (92 males; mean [SD] age 64 [11] years, mean [SD] left ventricular ejection fraction of 29 [6]%) were recruited and followed for 2 years during which 42 patients reached a clinical end‐point of all‐cause mortality and cardiovascular hospitalizations, including stroke and myocardial infarction. Plasma IL‐6 (P = 0·003) and TF (P = 0·013) levels, but not other research indices, were higher in those who suffered events compared with those without events. Predictors of end‐points were high (≥ median) TF (P = 0·011), and IL‐6 (P = 0·023) levels, as well as the lowest quartile of a left ventricular ejection fraction (P = 0·007). A strong correlation was present between TF and IL‐6 levels (r = 0·59; P < 0·0001) and with VEGF levels (r = 0·43; P < 0·0001). Conclusion IL‐6 and TF are predictors of poor prognosis in chronic CHF, raising the hypothesis that IL‐6 may contribute to the progression and thrombotic complications of CHF via its actions on TF expression. Although VEGF did not independently predict outcome in chronic CHF, the possibility arises that it may act with IL‐6 to induce TF expression.Keywords
This publication has 43 references indexed in Scilit:
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS studyEuropean Heart Journal, 2001
- Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-β1 in Serum of Patients With Acute Ischemic StrokeStroke, 2000
- Hypoxia-Induced Vascular Endothelial Growth Factor Expression Precedes Neovascularization after Cerebral IschemiaThe American Journal of Pathology, 2000
- Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery StudyBlood Coagulation & Fibrinolysis, 2000
- Tissue Factor pathwayBest Practice & Research Clinical Haematology, 1999
- Sudden unexpected cardiac death: methods and results of a national pilot surveyInternational Journal of Cardiology, 1995
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.The Journal of Experimental Medicine, 1984